Dr. John Campbell

Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis https://pubmed.ncbi.nlm.nih.gov/36597886/ Background Cases of adolescents and young adults developing myocarditis, after vaccination with (SARS-CoV-2)-targeted mRNA vaccines, reported globally, underlying immunoprofiles of these individuals have not been described in detail. Methods January 2021 through February 2022 Prospectively collected blood, from 16 patients, (12 to 21 years) 13 male 12 after 2nd dose Onset 4 days post vaccination hospitalized at Massachusetts General for Children, or Boston Children's Hospital, for myocarditis Presentation Chest pain Elevated cardiac troponin T, after SARS-CoV-2 vaccination. We performed Extensive antibody profiling, including tests for SARS-CoV-2-specific humoral responses, and assessment for autoantibodies, or antibodies against the human-relevant virome, SARS-CoV-2-specific T-cell analysis, and cytokine, and SARS-CoV-2 antigen profiling. Comparator group 45 healthy, asymptomatic, age-matched vaccinated control subjects. Results, things that were the same (Between the myocarditis group and non myocarditis group) Antibody profiling IgG and IgM the same T-cell responses the same (were essentially indistinguishable) Results, things that were different (Between the myocarditis group and non myocarditis group) In the myocarditis group Modest increase in cytokine production (reminiscent of the profile seen in MIS-C) Total leukocytes, specifically neutrophils, significantly increased Markedly elevated levels of full-length spike protein, (33.9±22.4 pg/mL), unbound by antibodies, were detected in the plasma of individuals with postvaccine myocarditis, No free spike was detected in asymptomatic vaccinated control subjects (unpaired t test; P<0.0001). Why spike protein persisted? In postvaccine myocarditis, the spike protein appears to evade antibody recognition, because the anti-spike antibodies that are generated are produced in adequate quantities with normal functional and neutralization capacity. UK https://www.nhs.uk/conditions/covid-19/covid-19-vaccination/getting-a-1st-and-2nd-dose-of-the-covid-19-vaccine/

German pathology Post vaccine, post mortem blood clots Not blood clots Formed after death (incompatible with life) Blood from a living patient with acute peripheral circulation ischaemia, (after cooling the blood sample) Might be a consolidation of proteins previously dissolved in the blood Professor Arne Burkhardt (Walter Lang) https://twitter.com/ArneBurkhardt https://prabook.com/web/arne.burkhardt/42818 https://swprs.org/covid-vaccine-injuries-the-german-pathologists-findings/ Original German language presentation https://www.youtube.com/watch?v=jLJXL3YlHKE Link page to translated version http://docs.shortxxvids.com/burkhardt_analysis.html 2nd conference on vaccine adverse events (English translation) https://odysee.com/@LongXXvids:c/Prof-Arne-Burkhardt---2nd-Vax-Injury-Conference---Part-1:1?&sunset=lbrytv Relatives turning to pathologists March 2022 onwards Suspecting deaths might be vaccine caused A disturbing and very complex histological picture 15 pathologic studies in the series so far Found patterns that can be attributed to vaccinations Methods Involved a range of other analytical specialists We have a toxicological problem before us Things have been overlooked in the past There is a poison at work which is produced in the body Which means we must look of it in the tissues Infection has been excluded Methodology test We have proved that spike protein in produced in the muscle it is injected into We are able now to prove that this can occur I almost all cells and organs the body Diffuse endothelialitis Endo thelial itis Active spike protein produced in adipose tissue Clustering around capillary endothelium (Biopsy from living patient, 8 months post vaccine) Left, swollen blood vessels with SP Right, brown stained SP with obliterative vasculitis Damage to vascular endothelium, thrombogenic exposure Foreign bodies in the lungs but not in the alveoli Also FBs found in the spleen, pancreas, heart Probably FBs are cholesterol ? Cholesterol released from atheromatous plaques Accumulation of protein, amyloid like deposits Found in tissues including the brain

Elon Musk accuses BBC of covering up vaccine side effects https://www.telegraph.co.uk/business/2023/04/12/elon-musk-bbc-interview-vaccine-side-effects-cover-up/ Full interview https://www.bbc.co.uk/news/av/world-us-canada-65249139 Mr. Musk Does the BBC hold itself at all responsible for misinformation regarding masking and side-effects of vaccinations and not reporting on that at all? And what about the fact that the BBC was put under pressure by the British government to change the editorial policy, are you aware of that? The BBC declined to comment on Mr Musk's claims. Mr Musk Spoken about having “major side effects” after 2nd covid vaccination Left him feeling as if he was “dying for several days.” The BBC’s liberal bubble has finally burst https://www.telegraph.co.uk/news/2023/04/13/the-bbcs-liberal-bubble-has-finally-burst/ Huge thanks to Musk for exposing the corporation’s groupthink with such forensic, dancing wit. Six things we learned from Elon Musk interview https://www.bbc.co.uk/news/world-us-canada-65251160 In March, Twitter said it removed 400,000 accounts in one month alone to help make Twitter safer. My experience is there is less misinformation rather than more

Oxford-AstraZeneca vaccine BBC, Lisa Shaw had first vaccination in May 2021 Died a week later. Aged 44 https://www.independent.co.uk/news/health/lisa-shaw-astrazeneca-vaccine-death-bbc-b2318224.html https://www.bbc.co.uk/news/uk-england-tyne-65187992 August 2021 Newcastle coroner Karen Dilks, Ruled Lisa had died from vaccine-induced thrombotic thrombocytopenia. Gareth Eve (widower) reached out attempted to engage with the government, MPs and three prime ministers It’s not in my make-up to turn around and say I want to sue somebody but for almost two years we’ve tried to engage with the government and tried to engage with MPs since Lisa died and not one of them has reached out or engaged with us at all. Any engagement is fleeting at best so that’s the reason that we’re left with no alternative – if the government or AstraZeneca don’t want to engage with us then what else are we supposed to do? These things have happened to too many people and we're made to feel like it's a dirty secret, that we're talking about something we shouldn't be talking about. It's established it's been caused by AstraZeneca's Covid vaccination – it's not about Covid, it's not about how many lives the Covid vaccination has saved, it's about what this vaccination has done to Lisa and other families and not about how successful it was or whether somebody is anti-vax. Mr Eve wanted some sort of acknowledgement or recognition that these deaths have occurred We’re not crackpots or conspiracy theorists, we’re husbands and wives and family members who have lost somebody – that’s all it is. Whatever the money, it’s not going to bring my son’s mam back. Consumer Protection Act 1987 Solicitor Peter Todd, Scott-Moncrieff and Associates the vaccine was a, defective product in that it was not as safe as consumers generally were reasonably entitled to expect. Department for Health and Social Care The Vaccine Damage Payments Scheme (VDPS) provides financial support to help ease the burden on individuals who have, in extremely rare circumstances, been severely disabled or died due to receiving a government-recommended vaccine. AstraZeneca told the BBC We are unable to comment on ongoing legal matters. Patient safety is our highest priority and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines. Our sympathy goes out to anyone who has reported health problems. Evidence showed the vaccine had, an acceptable safety profile the benefits outweigh the risks of extremely rare potential side effects.

A case of fatal multi-organ inflammation following COVID-19 vaccination https://www.sciencedirect.com/science/article/pii/S1344622323000548 14-year-old Japanese girl Healthy and active, athletic team Died unexpectedly Two days after receiving the third dose of the BNT1262b2 mRNA COVID-19 vaccine, (10th August 2022) Autopsy findings Congestive edema of the lungs T-cell lymphocytic and macrophage infiltration Lungs Pericardium Myocardium (left atria and left ventricle) Atrial myopericarditis Liver Kidneys Stomach Duodenum Bladder Diaphragm No preceding Infection Allergy Drug toxicity exposure Diagnosis Post-vaccination Pneumonia Myopericarditis Hepatitis Nephritis Gastroenteritis Cystitis Myositis Proximal cause of death Atrial myopericarditis probably caused fatal arrhythmia, Leading to cardiac failure and death. More details Post-vaccination myocarditis and pericarditis have been increasingly reported Male adolescents Higher incidence of pericarditis with a good prognosis Middle-aged and older patients More likely to have severe myocarditis The day after vaccination Developed a fever of 37.9 °C Some breathing difficulties The following morning Not breathing, pale appearance In cardiopulmonary arrest when paramedics arrived Resuscitated Died 45 hours after the third vaccination. After the first dose of vaccine on 12th September 2021 Arm pain without fever Day after the second dose on 3rd October 2021 Fever less than 38 °C Autopsy findings No superficial injuries were observed Heart showed no degeneration or scarring Both lungs showed severe pulmonary edema and congestion. A COVID-19 antigen quantification test, negative Numerous internal organ COVID-19 antigen tests, negative Serum, negative for adenovirus, cytomegalovirus, influenza A and B, RSV, EBV, enterovirus, parvovirus, HIV Histological findings Lymphocyte cellular infiltrates observed in the lungs, pericardium of both atria and adjacent myocardium, liver, kidneys, stomach, duodenum, and diaphragm Brain showed congestion Hippocampus a slight lymphocytic infiltrate Biochemical analysis Elevated SARS-CoV-2 antibody (43600 U/mL, normal less than 0.80) Elevated IL-6 (226 pg/mL, normal ≦4.0) Diagnosis Vaccine-related multiple-organ inflammation Vaccine-related myopericarditis, which led to severe arrythmias and progressive heart failure. Discussion However, adverse events caused by vaccines have been a problem.

In principle, no COVID-19 vaccination is recommended for spring/summer 2023. CDC You are up to date with your COVID-19 vaccines, https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html#children when you have completed a COVID-19 vaccine primary series, and got the most recent booster dose recommended for you by CDC. From the CDC site today (10th April) People aged 6 months through 64 years, and especially males aged 12 through 39 years, may consider getting the 2nd primary dose of Pfizer-BioNTech, Moderna, or Novavax 8 weeks after the 1st dose. Coronavirus: Vaccination In principle, no COVID-19 vaccination is recommended for spring/summer 2023. People at especially high risk can receive a vaccination following an individual consultation with their doctor. https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/impfen.html Is vaccination recommended for spring/summer 2023? In principle, no COVID-19 vaccination is recommended for spring/summer 2023. Nearly everyone in Switzerland has been vaccinated and/or contracted and recovered from COVID-19. Their immune system has therefore been exposed to the coronavirus. Seroprevalence data from mid-2022 98% + had antibodies against SARS-CoV-2. https://urbancare.clinic/switzerland-no-longer-recommends-covid-19-vaccination-heres-why/ Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm In spring/summer 2023, the virus will likely circulate less. The current virus variants also cause rather mild illness. For autumn 2023, the vaccination recommendation will be evaluated again and adjusted accordingly. What applies to people at especially high risk? In principle, it is also not currently recommended for people at especially high risk to receive a COVID-19 vaccination. They can, however, receive a vaccination following an individual consultation with their doctor. Vaccination may be wise in individual cases, as it improves protection against developing severe COVID-19 for several months. This applies regardless of the number of vaccinations you have already received. People at especially high risk include:  People aged 65 or over  People aged 16 or over with a chronic condition  People aged 16 or over with Down’s syndrome  Pregnant women If a wave of infection were to emerge in spring/summer 2023, the vaccination recommendation would be adjusted. If your doctor recommends that you get the COVID-19 vaccination, the following applies: Vaccination timing The COVID-19 vaccination can be given from 6 months after the last COVID-19 vaccination or from 6 months after a known coronavirus infection. Other vaccinations with inactivated vaccines can also be administered before, at the same time as or after a COVID-19 vaccination. Vaccine We advise you to get vaccinated with a bivalent (i.e. variant-adapted) mRNA vaccine, or with the protein-based Novavax vaccine. Which vaccine(s) you have previously received is of no importance here. Please note: If you are pregnant or breastfeeding, or if you have a severely weakened immune system, you should get yourself vaccinated with an mRNA vaccine.

Re-scheduling of psilocybin and MDMA https://www.tga.gov.au/resources/publication/scheduling-decisions-final/notice-final-decision-amend-or-not-amend-current-poisons-standard-june-2022-acms-38-psilocybine-and-mdma/re-scheduling-psilocybin-and-mdma-poisons-standard-questions-and-answers On 3 February 2023, TGA Permit prescribing of MDMA for the treatment of post-traumatic stress disorder (PTSD) Psilocybin for treatment-resistant depression (TRD) Psychiatrists who are specifically authorised under the TGA’s Authorised Prescriber scheme, effective from 1 July 2023. Legal psilocybin prescriptions in Canada (January 2022) https://www.drugscience.org.uk/canadians-can-now-be-legally-prescribed-psilocybin/ The SAP allows healthcare practitioners to request limited access to drugs that are not authorized for sale in Canada. https://www.psychiatrist.com/jcp/depression/identifying-difficult-treat-depression-differential/ Treatment-resistant depression (TRD) is common Responsible for much of the burden of major depressive disorder worldwide. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial https://journals.sagepub.com/doi/10.1177/0269881116675512?url_ver=Z39.88-2003 Clinically significant anxiety and depression Common in patients with cancer Associated with poor psychiatric and medical outcomes Double-blind, placebo-controlled trial Intervention Single-dose psilocybin (0.3 mg/kg), 70 Kg = 21mg in conjunction with psychotherapy. Assessed at 7 weeks Psilocybin produced immediate, substantial, and sustained improvements in anxiety and depression, and led to decreases in cancer-related demoralization and hopelessness, improved spiritual wellbeing, and increased quality of life. At the 6.5-month follow-up Psilocybin was associated with enduring anxiolytic and anti-depressant effects, 60–80% of participants continued with clinically significant reductions in depression or anxiety, sustained benefits in existential distress and quality of life, as well as improved attitudes towards death. The psilocybin-induced mystical experience mediated the therapeutic effect of psilocybin on anxiety and depression. Trial Registration: ClinicalTrials.gov Identifier: NCT00957359 Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists https://www.tga.gov.au/news/media-releases/change-classification-psilocybin-and-mdma-enable-prescribing-authorised-psychiatrists Medicines containing the psychedelic substances psilocybin, and MDMA (3,4-methylenedioxy-methamphetamine) Only conditions, currently sufficient evidence For potential benefits in certain patients, MDMA for treatment of post-traumatic stress disorder Psilocybin for treatment-resistant depression Acknowledges the current lack of options for patients with specific treatment-resistant mental illnesses https://www.tga.gov.au/sites/default/files/2023-02/notice-of-final-decision-to-amend-or-not-amend-the-current-poisons-standard-june-2022-acms-38-psilocybine-and-mdma.pdf Patients may be vulnerable during psychedelic-assisted psychotherapy, requiring controls to protect these patients. There are currently no approved products containing psilocybin or MDMA that the TGA has evaluated for quality, safety and efficacy. However, this amendment will allow authorised psychiatrists to access and legally supply a specified ’unapproved’ medicine containing these substances to patients under their care for these specific uses.

AstraZeneca is no longer available in Australia https://www.health.gov.au/our-work/covid-19-vaccines/advice-for-providers/clinical-guidance/tts#astrazeneca-is-no-longer-available-in-australia There was a link between the AZ vaccine and a rare but serious side effect, thrombosis with thrombocytopenia (TTS) AstraZeneca is no longer available as of 20 March 2023, so no further cases of AstraZeneca-related TTS can occur in Australia. BHF (UK) https://www.bhf.org.uk/informationsupport/heart-matters-magazine/news/coronavirus-and-your-health/astrazeneca-covid-vaccine Evidence shows that mRNA vaccines, Pfizer and Moderna, are more effective at boosting protection from Covid-19, so these vaccines are being recommended for the autumn booster programme. In Australia, the rate of AstraZeneca-related TTS Aged 60 and over 2 per 100,000 people vaccinated with AstraZeneca Aged under 60 2 to 3 per 100,000 people vaccinated with AstraZeneca Symptoms typically occurred between 4 and 42 days after a first dose TTS can cause long-term disability and death. TTS blood clotting (thrombosis) combined with low platelets (thrombocytopenia) Blood clots can appear in different parts of the body such as the brain or abdomen No risk factors were identified that predicted who developed TTS. Cases were reported in all ages, and in both men and women. TTS appeared to be more severe in younger women. Almost all reported cases of TTS occurred after the first dose of AstraZeneca. The risk of TTS was much lower after the second dose. The Oxford/AstraZeneca (ChAdOx1-S [recombinant] vaccine) COVID-19 vaccine: what you need to know https://www.who.int/news-room/feature-stories/detail/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know The vaccine is safe and effective for all individuals aged 18 and above. COVID-19 Vaccine AstraZeneca https://yellowcard.mhra.gov.uk/idaps/CHADOX1%20NCOV-19 Following AstraZeneca covid vaccination https://yellowcard.mhra.gov.uk https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting https://www.gov.uk/drug-safety-update/yellow-card-please-help-to-reverse-the-decline-in-reporting-of-suspected-adverse-drug-reactions 241 reports of myocarditis 226 reports of pericarditis 9 reports of endocarditis Oxford / AstraZeneca vaccine reaches two billion dose milestone https://www.ox.ac.uk/news/2021-11-16-oxford-astrazeneca-vaccine-reaches-two-billion-dose-milestone 2,000,000,000 16 November 2021 https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-COVID-19-vaccines.html Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccine is a viral vector vaccine and can be given in some situations. Australian timeline 8 April 2021 Australian Government received advice and recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) about AZ Thrombosis with Thrombocytopenia Syndrome 17 June 2021 ATGI, recommended an alternative to AstraZeneca for under 60s 20 March 2023 AZ discontinued

John is joined by professor Robert Clancy to discuss the current issues in immunology.

Omicron now and risky London research https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---30-march-2023 Covid, 3.6 million new cases (down 27% on the month) 25 000 deaths (down 39% on the month) Hospital admissions, down 9% ICU admissions down 5% As of 26 March 2023 761 million confirmed cases 6.8 million deaths Current trends in reported COVID-19 cases are underestimates of the true number of global infections and reinfections. Variants, geographic spread and prevalence 27 February to 26 March 2023 (28 days), 54, 922 SARS-CoV-2 sequences WHO closely tracking variant of interest, XBB.1.5 Six variants under monitoring (VUMs). BQ.1, BA.2.75, CH.1.1, XBB, XBF and XBB.1.16 XBB.1.16 is a recombinant of BA.2.10.1 and BA.2.75 (three additional mutations in the SARS-CoV-2 spike protein) Reports do not indicate a rise in hospitalizations, ICU admissions, or deaths due to XBB.1.16. Globally XBB.1.5 accounts for 45.1% of cases BQ.1, BA.2.75 declined CH.1.1 and XBF remained stable Civil Service, long covid, September and October 2022 https://www.telegraph.co.uk/politics/2023/03/31/twice-as-many-civil-servants-long-covid-national-average/ 10 – 10.8 %, declared the condition in autumn 2022 7.4 % affecting their day-to-day life (3.3 % of the general public) Year to March 2022 Poor mental health Musculoskeletal problems Others Long covid Periods off sick, less than 20 working days 32.4 % of all absences

WHO’s Strategic Advisory Group of Experts https://www.who.int/news/item/28-03-2023-sage-updates-covid-19-vaccination-guidance revised the roadmap for prioritizing the use of COVID-19 vaccines, to reflect the impact of Omicron and high population-level immunity due to infection and vaccination. The roadmap newly considers the cost-effectiveness of COVID-19 vaccination for those at lower risk – namely healthy children and adolescents – Revised roadmap reemphasizes the importance of vaccinating those still at-risk of severe disease, mostly older adults and those with underlying conditions, Chair Dr Hanna Nohynek. “Countries should consider their specific context in deciding whether to continue vaccinating low risk groups, like healthy children and adolescents, while not compromising the routine vaccines that are so crucial for the health and well-being of this age group.” The high priority group and frontline health workers. SAGE recommends an additional booster of either 6 or 12 months after the last dose, Medium priority group healthy adults – usually under the age of 50-60 – without comorbidities Although additional boosters are safe for this group, SAGE does not routinely recommend them, The low priority group healthy children and adolescents aged 6 months to 17 years. Primary and booster doses are safe and effective in children and adolescents. The public health impact of vaccinating healthy children and adolescents is comparatively much lower than the established benefits of traditional essential vaccines for children Vaccinating pregnant persons – including with an additional dose if more than 6 months have passed since the last dose – protects both them and the fetus Other meeting highlights include: Polio, OPV Regional reports on measles With measles cases increasing in all WHO regions in 2022 In 2021, with 25 million children missing out. Status of new tuberculosis vaccines Tuberculosis (TB) is a leading cause of death and a vaccine that prevents disease in adolescents and adults is urgently needed. A substantial effort for vaccine development is underway, with several candidates in late-stage clinical trials Malaria Introducing the RTS,S malaria vaccine has resulted in a substantial reduction in severe malaria and all-cause mortality among age eligible children.

Covid symptom data mild, excess deaths high https://health-study.joinzoe.com Sore throat 59% Runny nose 54% Blocked nose 52% Headache 51% Sneezing 50% Cough, no phlegm 49% Cough with Phlegm 41% Hoarse voice 36% Muscle aches pains 27% Fatigue 20% Altered smell 20% Dizzy light headed 19% Swollen neck glands 17% Sore eyes 16% Loss of smell 16% Chest pain tightness 14% Short of breaths 13% Earache 13% Shivers or chills 13% Fever 11% https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/weekending17march2023 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/latest England Estimated number of people testing positive for COVID-19 1,493,200 Equating to 2.66% of the population, or around 1 in 40 people. Week ending 17 March 2023 (Week 11) 12,133 deaths registered in England and Wales 559 deaths mentioned novel coronavirus (COVID-19), accounting for 4.6% of all deaths. Of the 559 deaths involving COVID-19 67.3% (376 deaths) had this recorded as the underlying cause of death The number of deaths was above the five-year average In private homes 23.2% above, (674 excess deaths) In hospitals 4.6% above, (232 excess deaths) In care homes 4.7% above, (112 excess deaths) In other settings 6.9% above, (55 excess deaths) Number of deaths registered in the UK in the week ending 17 March 2023 13,683, (9.3% above the five-year average) Thats 1,169 more deaths than the five-year average Excess deaths https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/monthlymortalityanalysisenglandandwales/december2022#excess-mortality-in-england-and-wales The difference between the observed deaths within a period compared with the five-year average (2016 to 2019, and 2021) Probably multifactorial Excess deaths have occurred around the world Let’s look for a common (or group of) underlying cause that would explain the tragedy. It may transpire there is a common factor (s)

Good point, we have seen the tragedy of this many times of course, one person, armed and with a grudge British experiments https://www.telegraph.co.uk/news/2023/03/18/how-british-experiments-risked-making-covid-pandemic-lethal/ Risked making the Covid pandemic ‘more lethal’ In testing, Imperial College London Experiments took place in London Supported by the UK Health Security Agency (UKHSA) Cells were infected with delta and omicron, at the same time, to see which had a competitive advantage. Professor Anton van der Merwe, molecular immunology, University of Oxford Risked combining the two variants, to produce something “more lethal” Infected scientists, could walk out of the lab. “Coronaviruses like Sars-CoV-2 are well known to ‘evolve’ by exchanging genetic material, when two distinct viruses infect the same cell,” This makes it much more likely that these two strains will recombine, and create a more dangerous variant, which could infect those doing the experiments, who could then spread it into the community.” Using delta and omicron, particularly risky, from different lineages, with significant differences Professor Anton van der Merwe, There is more opportunity for recombination in animal experiments and selection for more dangerous variants because they involve more cells infected for longer periods, Handling animals is also riskier in terms of transmission to the experimenter than handling cells. Neither of these experiments are of any help in protecting us from Sars-CoV-2. Dr Filippa Lentzos, Centre for Science and Security Studies King’s College London “There has been a global boom in construction of labs handling dangerous pathogens, but this has not been accompanied by sufficient biosafety and biosecurity oversight.” Imperial College London “This government-backed research used viruses no more pathogenic than those already circulating within the population and will provide crucial insights that support government decision-making on how to manage the pandemic. “It was conducted in a biosafety level three laboratory in line with strict government regulations, and received ongoing approval from the Health and Safety Executive.” https://consteril.com/biosafety-levels-difference/ Wuhan IV, biosafety level 4 (BSL4) One of 59 around the world Three quarters in urban settings (like London) Past lab leaks Smallpox, swine flu, SARS, anthrax, foot and mouth disease Report by King’s College London https://www.kcl.ac.uk/fifty-nine-labs-around-world-handle-the-deadliest-pathogens-only-a-quarter-score-high-on-safety Did the coronavirus SARS-CoV-2 result from high-risk research gone wrong? The risk of future pandemics originating from research with dangerous pathogens is real. BSL4 labs Europe, 25 labs North America, 14 and Asia, 13 Australia, 4 Africa,3 With 3,000m² of lab space, the Wuhan Institute of Virology is the largest BSL4 lab in the world

Sir Christopher Chope.

UK, Vaccine injuries https://www.telegraph.co.uk/news/2023/03/24/vaccine-damage-payment-scheme-boosts-staff-numbers-four-80-covid/ https://www.telegraph.co.uk/news/2023/03/27/young-women-had-35-times-higher-risk-death-heart-issues-astrazeneca/ The Vaccine Damage Payment Scheme (VDPS) https://www.gov.uk/vaccine-damage-payment Admin workers, 4 up to 80 20 fold increase Increasing demand for Covid vaccine injury payments A project, to digitalise application process If you’re severely disabled as a result of a vaccination against certain diseases, you could get a one-off tax-free payment of £120,000. This is called a Vaccine Damage Payment. You can also apply for this payment on behalf of someone who has died after becoming severely disabled because of certain vaccinations. You could get a payment if you’re severely disabled and your disability was caused by vaccination against any of the following diseases: • coronavirus (COVID-19) • diphtheria • haemophilus influenzae type b (Hib) • human papillomavirus • influenza, except for influenza caused by a pandemic influenza virus • measles • meningococcal group B (meningitis B) • meningococcal group C (meningitis C) • meningococcal group W (meningitis W) • mumps • pandemic influenza A (H1N1) 2009 (swine flu) - up to 31 August 2010 • pertussis (whooping cough) • pneumococcal infection • poliomyelitis • rotavirus • rubella (German measles) • smallpox - up to 1 August 1971 • tetanus • tuberculosis (TB) You may also be able to get a payment if you’re severely disabled because, your mother was vaccinated against one of the diseases in the list while she was pregnant What counts as ‘severely disabled’? Disablement is worked out as a percentage, and ‘severe disablement’ means at least 60% disabled. This could be a mental or physical disablement, and will be based on medical evidence from the doctors or hospitals involved in your treatment. The Hausfeld Claimant group A group of patients and families are now taking legal action against AstraZeneca, after they suffered injury or bereavement as a result of complications from the Covid vaccine. https://www.hausfeld.com/en-gb/news/claimant-group-brings-legal-claim-against-astrazeneca-under-consumer-protection-act-1987/ 13 bereaved families, and 28 survivors, “Vaccine Induced Thrombocytic Thrombocytopenia” Consumer Protection Act 1987, argues that the AstraZeneca vaccine was “defective”, in that it was not as safe as individuals were entitled to expect. VITT is now established as causatively linked with the AstraZeneca vaccine. (Hausfeld) (18% case fatality rate) Freedom of Information (FOI) March 2023 4,017 claims, submitted since Nov 1 2021. Payment scheme taken over by NHS Business Services Authority in November 2021 https://www.nhsbsa.nhs.uk Of the 4,017 claims made, 334 relate to a claimant who has died. ‘Balance of probabilities’ Patient’s medical records, “all scientific evidence” Rishi Sunak “We are taking steps to reform vaccine damage payments schemes by modernising the operations and providing more timely outcomes, but of course I'd be happy to talk to the honourable gentleman further about it.” Mrs. Sheila Ward Stephen, 57, Oxford AZ in March 2021 Mr Ward had no pre-existing conditions Headache after a few days Taken to hospital, treated for stroke Bleeds and clots on his brain Coroner’s certificate, vaccine as one of the causes “For anyone who has been left with a lifelong disability or young children, it simply wouldn’t be enough to replace somebody's income.” Ms Spit “The [60 per cent disabled] criteria is a really big [issue], because there are so many people just left with nothing after being severely injured, and have life-changing disabilities, ‘well you’re not interested enough’ https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety.html Note, and limiting the spread of the virus that causes it. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html Groups recommended for vaccination COVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19.

Sweden, Lockdown was never on the agenda https://www.telegraph.co.uk/news/2023/03/23/anders-tegnell-swedens-pandemic-plan-lockdown-never-agenda/ Dr. Anders Tegnell ‘Lockdown was never on the agenda in Sweden’ Sweden’s state epidemiologist (medical) UK, SPI-B (Scientific Pandemic Influenza Group on Behaviour) To increase adherence, “perceived level of personal threat needs to be increased” Professor Neil Ferguson (Imperial College) Letting the virus spread freely in the UK 510,000 deaths Anders Tegnell “If you put numbers into models and you don’t know those numbers are fairly much correct, you can arrive at very, very strange results.” “You need to weigh together different sources of science and then you can maybe arrive at something that’s reasonably, hopefully true,” “And you need to really double-check and see if you get more people doing the same thing before you can feel reasonably safe. But to rely very much on just one study, one model, that’s quite dangerous.” Swedish people, advised to work from home wherever possible Ban on gatherings of over 50 people A few rules for restaurants Other Covid measures, entirely voluntary Johan Giesecke, (previous state epidemiologist) “apolitical – one of those people who did what they were supposed to without reflecting too much on what was expedient or politically viable at the time” Anders Tegnell “If you go back to the Spanish flu (1918-19), you can find instances when they tried to lock things down,” “But in all the pandemic plans we have been discussing during the last decades, closing down a society has never even been on the agenda.” Shutting down short term? “I mean, if you know that your healthcare system needs a few weeks to ramp up the ICU and so on, there are instances when such things can be a solution.” Airborne respiratory virus was going to sweep through the population anyway, The best you could hope for was to slow it down while protecting the vulnerable The cost of lockdown would be horrifyingly high Was the world influenced by China? ‘China is, of course, a state where draconian things like that can be done,” “And it did work to a certain extent. So, for a while, there was an idea that we should have very strict measures like a hammer coming down. Bam! Bring the hammer down hard and then take the hammer away and then sort of let it slowly build up again and then, bam! But that never worked.” “We learn quite soon that it’s easy to start having different kinds of restrictions, but it’s very difficult to stop having them.” No billboards with scary pictures of Covid patients, no masks, no street furniture of fear Mobile phone records, Swedes chose to restrict travel and social activities People told it was safest to be outdoors Swedish national parks very busy Denmark and Norway Closed all schools on March 11th Sweden Over-16s and university, moved to remote learning Younger children, in class as normal March 13, Johan Giesecke to Anders Tegnell Don’t you know, my son, with how little wisdom the world is governed? Anders Tegnell “The world has gone mad” In Sweden, it’s even written into the law that the health care should be driven by evidence-based medicine and that was so quickly left behind in other places.” Stefan Lofven, Sweden’s prime minister Played no part in the 2pm daily press briefings Telegraph there was no baying for blood like there was from the British media as broadcasters with GCSE biology screeched at hapless UK ministers to hurry up and shut the schools.

Therapeutic Goods administration January 2021 https://www.tga.gov.au/sites/default/files/foi-2389-06.pdf

Therapeutic Goods administration January 2021 https://www.tga.gov.au/sites/default/files/foi-2389-06.pdf Page 4 “Almost similar microscopic lung inflammation was observed in both challenged control and immunised animals (macaques) after the peak of infection (Days 7/8)” Challenged with infection, (unvaccinated) control animals Almost similar microscopic lung inflammation Challenged with infection, immunized (vaccinated) animals Almost similar microscopic lung inflammation Page 4 “There are no distribution and degradation data on the S antigen-encoding mRNA.” A new therapy that uses an intra-cellular pathway to use intracellular ribosomes We know from page 45 the lipid nanoparticles are systemically distributed, But the spike protein that the RNA produces, distribution not tested No data on how long the spike protein persists Page 5 “Antibodies and T cells in monkeys declined quickly over 5 weeks after the second dose of BNT162b2 (V9), raising concerns over long term immunity” Page 6 – A few unknowns were identified by the TGA “Short term protection studies, lack of pharmacokinetic data for the S antigen-encoding mRNA (BNT162b2 V9), suboptimal dosing interval in the repeat dose study, lack of repeat dose toxicity studies in a second species, and genotoxicity studies with the novel excipients, (a substance formulated alongside the active ingrediants) and lack of studies investigating potential for autoimmune diseases were noted.” Page 6 – Unknown go on “Long term immunity, vaccine induced autoimmune diseases were not studied in the nonclinical program” Page 8 “BNT162b2 immunisation also induced proinflammatory cytokines such as GM-CSF, TNF-α, IL-6 and IL-18, in addition to IFN-γ, in splenocytes.” Page 9 “One study found that among people who had recovered from COVID-19, 100% had S protein-specific CD4+ T cells in the circulation and 70% had S protein-specific CD8+ T cells in the circulation

TGA Pfizer document https://www.tga.gov.au/sites/default/files/foi-2389-06.pdf Tissue distribution (lipid nanoparticles encapsulation RNA) (Page 44) Rats after i.m. vaccine injection The concentration of radioactive lipid marker reached the peak level in plasma (8.9 μg lipid eqv/mL), between 1 – 4 h post-dose, and distribution mainly into liver, adrenal glands, spleen and ovaries over 48 h Concentrations were higher in plasma than in blood, with mean blood: plasma ratios of 0.5 – 0.6. DISTRIBUTION (page 40) The distribution of LNP-BNT162b2 (V9) mRNA or expressed S protein was not studied. Table 4-2. Mean concentration of radioactivity (sexes combined) in tissue and blood following a single IM dose of 50 μg mRNA/rat (page 45) Mean total radioactivity was greatest at the injection site followed by the liver, with much lower total recovery in spleen, adrenal glands and ovaries The tissue distribution pattern was similar in 100 μg mRNA/animal dose group as noted above for 50 μg mRNA/animal dose, with highest distribution into liver, adrenal glands and spleen. Conclusions Slow but significant distribution of lipid nanoparticles from the site of injection with major uptake into liver. Minor distribution in spleen, adrenal glands and ovaries over 48 h. Mean blood:plasma ratios of 0.5-0.6 indicating nanoparticles mainly present in plasma fraction of blood with peak concentrations in plasma at approx. 2 h post-dose.

Australian Government document on Pfizer vaccine dated January 2021 with Senator Rennick. Thank you Senator. https://www.tga.gov.au/sites/default/files/foi-2389-06.pdf

Just what is going on in this video?